Search research articles
Contact Us
Filters
Showing results (61-70 of 131) with videos related to
Page
of 14
Sort By:
Scientific Reports
|
August 20, 2021
Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI
Lennart Well, Anna Careddu, Maria Stark, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
June 10, 2020
Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndrome
Hagit Toledano-Alhadef, Victor-Felix Mautner, Isabel Gugel, et al.
Orphanet Journal of Rare Diseases
|
January 15, 2021
Structural alteration of lung parenchyma in patients with NF1: a phenotyping study using multidetector computed tomography (MDCT)
Maxim Avanesov, Lennart Well, Azien Laqmani, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
June 16, 2020
Presenting symptoms in children with neurofibromatosis type 2
Isabel Gugel, Florian Grimm, Christian Teuber, et al.
International Journal of Molecular Sciences
|
February 28, 2020
Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In Vivo
Alexander Schulte, Florian Ewald, Melanie Spyra, et al.
Orphanet Journal of Rare Diseases
|
November 3, 2021
Alterations in brain morphology by MRI in adults with neurofibromatosis 1
Su Wang, Victor-Felix Mautner, Ralph Buchert, et al.
Cancers
|
November 27, 2019
Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients
Isabel Gugel, Lan Kluwe, Julian Zipfel, et al.
Neuro-Oncology
|
February 13, 2010
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2
Victor-Felix Mautner, Rosa Nguyen, Hannes Kutta, et al.
Computers in Biology and Medicine
|
December 28, 2025
MOIS-SAM2: Exemplar-based segment anything model 2 for multi-lesion interactive segmentation of neurofibromas in whole-body MRI
Georgii Kolokolnikov, Marie-Lena Schmalhofer, Sophie Götz, et al.
Brain : a Journal of Neurology
|
December 7, 2013
Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling
Alexander Schulz, Anna Kyselyova, Stephan L Baader, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 131) with videos related to
Sort By:
Page
of 14
Scientific Reports
|
August 20, 2021
Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI
Lennart Well, Anna Careddu, Maria Stark, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
June 10, 2020
Role, function and challenges of multidisciplinary centres for rare diseases exemplified for neurofibromatosis type 1 syndrome
Hagit Toledano-Alhadef, Victor-Felix Mautner, Isabel Gugel, et al.
Orphanet Journal of Rare Diseases
|
January 15, 2021
Structural alteration of lung parenchyma in patients with NF1: a phenotyping study using multidetector computed tomography (MDCT)
Maxim Avanesov, Lennart Well, Azien Laqmani, et al.
Child'S Nervous System : Chns : Official Journal of the International Society for Pediatric Neurosurgery
|
June 16, 2020
Presenting symptoms in children with neurofibromatosis type 2
Isabel Gugel, Florian Grimm, Christian Teuber, et al.
International Journal of Molecular Sciences
|
February 28, 2020
Combined Targeting of AKT and mTOR Inhibits Proliferation of Human NF1-Associated Malignant Peripheral Nerve Sheath Tumour Cells In Vitro but not in a Xenograft Mouse Model In Vivo
Alexander Schulte, Florian Ewald, Melanie Spyra, et al.
Orphanet Journal of Rare Diseases
|
November 3, 2021
Alterations in brain morphology by MRI in adults with neurofibromatosis 1
Su Wang, Victor-Felix Mautner, Ralph Buchert, et al.
Cancers
|
November 27, 2019
Minimal Effect of Bevacizumab Treatment on Residual Vestibular Schwannomas after Partial Resection in Young Neurofibromatosis Type 2 Patients
Isabel Gugel, Lan Kluwe, Julian Zipfel, et al.
Neuro-Oncology
|
February 13, 2010
Bevacizumab induces regression of vestibular schwannomas in patients with neurofibromatosis type 2
Victor-Felix Mautner, Rosa Nguyen, Hannes Kutta, et al.
Computers in Biology and Medicine
|
December 28, 2025
MOIS-SAM2: Exemplar-based segment anything model 2 for multi-lesion interactive segmentation of neurofibromas in whole-body MRI
Georgii Kolokolnikov, Marie-Lena Schmalhofer, Sophie Götz, et al.
Brain : a Journal of Neurology
|
December 7, 2013
Neuronal merlin influences ERBB2 receptor expression on Schwann cells through neuregulin 1 type III signalling
Alexander Schulz, Anna Kyselyova, Stephan L Baader, et al.
Page
of 14